ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "Capvaxive" (8)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Pneumococcus, Purified Polysaccharides Antigen Conjugated (J07AL02) 8 products WHO-DDD DrugBank.ca 
L IP V/SCapvaxive 63.8485.8510 %Injection solution in prefilled syringe: 18 Active AgentsMSD Merck Sharp &
Dohme AG
B / SLG
L IP V/SVaxneuvance 56.5677.9510 %Injection suspension: 10 Active AgentsMSD Merck Sharp &
Dohme AG
B / SLG
L IP V/SVaxneuvance10565.61631.5510 %Injection suspension: 10 Active AgentsMSD Merck Sharp &
Dohme AG
B / SLG
L IP V/SPrevenar 13Fertigspritze(n) à 0.5 ml56.3477.7010 %Injektionssuspension in einer Fertigspritze: 8 Active AgentsPfizer AGB / SLG
L IP V/SPrevenar 20 59.2180.8010 %Injektionssuspension in einer Fertigspritze: 14 Active AgentsPfizer AGB / SLG
L IP V/SPrevenar 2010592.10660.3510 %Injektionssuspension in einer Fertigspritze: 14 Active AgentsPfizer AGB / SLG
  IP V/SPrevenar 1310 1 Fertigspritze(n) à 0.5 mlk.A.Injektionssuspension in einer Fertigspritze: 8 Active AgentsPfizer AGBG
  IP V/SCapvaxive10k.A.Injection solution in prefilled syringe: 18 Active AgentsMSD Merck Sharp &
Dohme AG
BG
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home